Two Sigma Investments, LP Synthetic Biologics, Inc. Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.9 - $2.9 $3,418 - $5,217	-1,799 Reduced 1.1%	161,373 $34,000
Q1 2022 May 16, 2022	BUY	$2.3 - $4.3 $181,923 - $340,117	79,097 Added 94.08%	163,172 $47,000
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.5 $348,300 - $580,500	-129,000 Reduced 60.54%	84,075 $23,000
Q3 2021 Nov 15, 2021	BUY	$4.3 - $5.8 $822,590 - $1.11 Million	191,300 Added 878.53%	213,075 $98,000
Q2 2021 Aug 16, 2021	BUY	$4.6 - $7.2 $100,164 - $156,780	21,775 New	21,775 $13,000
Q1 2019 May 15, 2019	SELL	$5.9 - $8.1 $63,891 - $87,714	-10,829 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$5.2 - $26.8 $56,310 - $290,217	10,829 New	10,829 $6,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.